It is difficult to directly compare Mounjaro and Wegovy because they work in slightly different ways, contain different active ingredients, and are administered in different doses
Repeat labs at 46 week intervals during dose escalation, then quarterly once stable
The STEP trials tracked semaglutide safety over 68 weeks with favorable results, and real-world data on thousands of patients using GLP-1 for 13+ years shows stable tolerability
Numerous examples exist of photocrosslinking lipids across all major classes of lipids, including sterols, glycerolipids, and sphingolipids, and they have been applied to identify many previously unknown lipidprotein interactions, as summarized in Table 3 and reviewed in detail elsewhere
Link administration to an existing habit (morning coffee, evening skincare routine)
Food and Drug Administration (FDA) also approved semaglutide for long-term weight management under the brand name Wegovy